The Co-Infection Workshop 2018 will feature an exceptional program with invited lectures, round table discussions and interactive participation from delegates. The preliminary program is published below:


Pre-workshop Educational Course
Wednesday 16 May

 9:30HCV in 2018
Jürgen Rockstroh, MD, University of Bonn, Germany

HBV: diagnostics, management and screening
Douglas Dieterich, MD, Mount Sinai Medical Centre, New York, NY, USA

 10:35Coffee break
 11:05Liver care in HIV- mangement of abnormal LFTs
 11:30NAFLD: diagnostics, management and screening
Sanjay Bhagani, BSc FRCP, Royal Free Hospital, London, UK
 11:55Fibrosis Markers and Cirrhosis management in HIV patients
Kenneth Sherman, MD, PhD, University of Cincinnati, OH, USA

14th International Workshop on Co-infection: HIV, Hepatitis and Liver Disease

  Session 1: Management of Hepatitis C - part 1
 14:10DAA:  will generics change the landscape? 

HCV care after cure
Raffaele Bruno, MD, University of Pavia, Italy

 15:00Abstract - driven presentations 
 15:30Coffee break
  Session 2: Management of Hepatitis C - part 2
 16:00Roundtable discussion: the WHO report on HCV elimination
 16:40Abstract - driven presentations 
  17:45Welcome reception & Poster viewing session 1

Thursday 17 May 2018

 Session 3: Management of Hepatitis B - part 1

HBV managment in HIV patients 
Karine Lacombe, MD, PhD, Hôpital Saint Antoine Paris, France

 8:55HBV Novel Therapies
Maria Buti, MD,PHD Hospital Universitario Valle Hebron, Barcelona, Spain
  9:20Abstract - driven presentations 
 10:20Coffee break and poster viewing session 2
 Session 4: Management of Hepatitis B - part 2

Debate: TDF vs. TAF in HBV management
Mark Nelson, MD, Chelsea and Westminster Hospital, London, UK

 12:00Abstract - driven presentations 
 Session 5: Best of posters
 14:006 - 8 best of posters
 Session 6: NAFLD and HIV

NAFLD in HIV- infected patients
Juan Macías, MD, PhD, Hospital de Valme, Seville, Spain

 15:25Abstract - driven presentations
 16:10Coffee Break
 16:40Industry - sponsored symposium

Friday 18 May 2018

 8:30Industry - sponsored symposium
 Session 7: Fibrosis markers in liver disease
  9:30The role of Fibroscan: pre and post SVR
Nicolás Merchante, MD, Hospital de Valme, Seville, Spain
 10:10Coffee break
 Session 8: Hepatitis A in HIV
 10:40Roundtable Discussion: Hepatitis A in HIV: the French, Italian and Spanish perspective
 11:30Epidemiology, diagnostics and treatment of Hepatitis E
Harry Dalton, MD,  Royal Cornwall Hospital NHS Trust, U.K
 Invited speakers